Validation of CD271 as a Therapeutic Target of Squamous Cell Carcinoma
Project/Area Number |
15K14414
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Tumor therapeutics
|
Research Institution | Miyagi Prefectural Hospital Organization Miyagi Cancer Center |
Principal Investigator |
TANAKA NOBUYUKI 地方独立行政法人宮城県立病院機構宮城県立がんセンター(研究所), がん先進治療開発研究部, 部長 (60280872)
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | がん / 免疫抑制 / 癌 / 癌幹細胞 |
Outline of Final Research Achievements |
In order to validate a potential of CD271 as a squamous cell carcinoma target, CD271 was knock-downed by shRNA. CD271 inhibition inhibited both cell proliferation and migration. p42/44Erk inhibition as well as RhoA inhibition inhibited malignant phenotypes of HPCM2 cells. On the other hand, an anti-CD271 Ab did not show significant in vitro effect on the same cells. Together, CD271 is shown to be a potential target for squamous cell carcinoma therapy.
|
Report
(3 results)
Research Products
(10 results)
-
[Journal Article] ESCRT-0 dysfunction compromises autophagic degradation of protein aggregates and facilitates ER stress-mediated neurodegeneration via apoptotic and necroptotic pathways2016
Author(s)
Oshima R, Hasegawa T, Tamai K, Sugeno N, Yoshida S, Kobayashi J, Kikuchi A, Baba T, Futatsugi A, Sato I, Satoh K, Takeda A, Aoki M and Tanaka N
-
Journal Title
Scientific Reports
Volume: 6
Issue: 1
Pages: 24997-24997
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
[Journal Article] Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription.2016
Author(s)
Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, Tanaka N, Moriguchi T, Motohashi H, Nakayama K, Yamamoto M.
-
Journal Title
Nat Commun
Volume: 7
Issue: 1
Pages: 11624-11624
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
[Journal Article] CD271 regulates the proliferation and motility of hypopharyngeal cancer cells2016
Author(s)
Mochizuki M, Tamai K, Imai T, Sugawara S, Ogama N, Nakamura M, Matsuura K, Yamaguchi K, Satoh K, Sato I, Motohashi H, Sugamura K, Tanaka N
-
Journal Title
Sci Rep
Volume: 6
Issue: 1
Pages: 30707-30707
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Enhanced expression of semaphorin 3E is involved in the gastric cancer development.2016
Author(s)
Maejima R, Tamai K, Shiroki T, Yokoyama M, Shibuya R, Nakamura M, Yamaguchi K, Abue M, Oikawa T, Noguchi T, Miura K, Fujiya T, Sato I, Iijima K, Shimosegawa T, Tanaka N, Satoh K.
-
Journal Title
Int J Oncol.
Volume: 49(5)
Issue: 3
Pages: 619-28
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Xenotransplantation elicits salient tumorigenicity of adult T-cell leukemia-derived cells via aberrant AKT activation.2016
Author(s)
Yamaguchi K, Takanashi T, Nasu K, Tamai K, Mochizuki M, Satoh I, Ine S, Sasaki O, Satoh K, Tanaka N, Harigae H, Sugamura K.
-
Journal Title
Cancer Sci.
Volume: ePub
Issue: 5
Pages: 638-643
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-